Anesth Pain Med.  2007 Jul;2(3):122-125.

Optimal Priming Dose of Rocuronium for Prevention of Succinylcholine Induced Fasciculations

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, College of Medicine, Ewha Womans Univeristy, Seoul, Korea.
  • 2Department of Anesthesiology and Pain Medicine, College of Medicine, Guro Hospital, College of Medicine, Korea University, Seoul, Korea. Lsh1102@unitel.co.kr

Abstract

BACKGROUND: Subparalyzing dose of nondepolarizing muscle relaxants is often given prior to succinylcholine to reduce its adverse effects. At the same time, priming dose may worsen the intubating condition due to its antagonizing effect at neuromuscular junction. Although optimal priming dose of rocuronium is known to 0.03-0.04 mg/kg but higher priming dose may reduce interval from priming drug to succinylcholine. This study was designed to determine the maximal priming dose of rocuronium.
METHODS
Sixty ASA I or II adult patients were randomized into three groups: group R1 received 0.06 mg/kg of rocuronium, group R2, 0.09 mg/kg and group Scc, normal saline. About 3 minutes after priming dose, thiopental 4 mg/kg, fentanyl 1microg/kg and succinylcholine 2 mg/kg were administered for anesthesia induction. The presence and severity of fasciculations and intubating conditions were evaluated with the incidence of side effects.
RESULTS
In preventing fasciculations, group R1 and R2 were significantly better than group Scc, without significant difference between group R1 and R2. Intubation conditions were significantly worse in group R2 than in group Scc.
CONCLUSIONS
The maximal priming dose of rocuronium to prevent fasciculations and optimizing intubating condition was 0.06 mg/kg.

Keyword

fasciculations; precurarization; rocuronium; succinylcholine

MeSH Terms

Adult
Anesthesia
Fasciculation*
Fentanyl
Humans
Incidence
Intubation
Neuromuscular Junction
Succinylcholine*
Thiopental
Fentanyl
Succinylcholine
Thiopental
Full Text Links
  • APM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr